Related Experiment Video
Updated: Apr 10, 2026

Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
Association Between Serum PADI-4 Levels and Disease Activity in Ulcerative Colitis Patients
Semiha Şimşek1, Elvan Işık2, Betül Çiğdem Yortanlı1
1Department of Internal Medicine, Konya City Hospital, Konya, Türkiye.
Objectives:
PADI-4 is a member of the peptidyl arginine deiminase enzyme family. This enzyme is expressed by inflammatory cells and plays an important role in inflammation and immune responses. In this study, we aimed to evaluate serum PADI-4 levels in patients with ulcerative colitis (UC) and to investigate the relationship between PADI-4 and disease activity.
Material And Method:
Fifty-one patients with UC and 31 healthy controls were included in this observational study. First, serum PADI-4 levels in patients with UC and the control group were compared. Subsequently, serum PADI-4 levels were analyzed in UC patients with active disease and those who are in remission, separately. Finally, the impact of PADI-4 on predicting disease activity was evaluated by performing correlation analyses between serum PADI-4 and C-reactive protein (CRP) in addition to the total Mayo score (TMS) and modified Mayo Endoscopic Subscore (MESS).
Results:
Serum mean PADI-4 levels were found to be significantly higher in the UC group (1317 ± 818 pg/mL) compared to the control group (873 ± 622 pg/mL) (p: 0.009). Serum mean PADI-4 levels were significantly different between the three groups (patients with remission, mild disease, and moderate/severe disease group) (p: 0.015) (1076 ± 609, 1073 ± 683, and 1802 ± 943 pg/mL, respectively). In Spearman's correlation analysis, it was determined that there was a positive and significant relationship between PADI-4 and CRP levels (r = 0.31, p: 0.027) in addition to TMS (r = 0.419, p: 0.02) and MESS (r = 0.417, p: 0.002). The ideal serum PADI-4 levels for predicting disease activity were found to be 980 pg/mL.
Conclusion:
Our study revealed that serum PADI-4 levels were higher in patients with UC compared to healthy controls and might be an effective marker to determine disease severity.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Ulcerative Colitis in IBD
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

